ConductScience.org, home

Paper692279

A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.

Jenner P and 4 others. Life Sci, 1978. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs. Papers, record 692279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/692279

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
PubMed
Journal
Life Sci
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
3.86
iCite
Revised in PubMed
2019-07-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jenner PP
2Clow AA
3Reavill CC
4Theodorou AA
5Marsden CDC D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Behavior, AnimalMajor topic
BenzamidesMajor topic
BrainMajor topic
HaloperidolMajor topic
Receptors, DopamineMajor topic
Adenylyl Cyclases
Animals
Female
Homovanillic Acid
Male
Mice
Rats

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
7862816Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats.Psychopharmacology (Berl)1993https://conductscience.org/library/papers/7862816PubMed
7516074Palliative medicine.Postgrad Med J1993https://conductscience.org/library/papers/7516074PubMed
7155198Differential effects of sulpiride and metoclopramide on brain. Homovanillic acid levels and shuttle box avoidance after systemic and intracerebral administration.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/7155198PubMed
6798615Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6798615PubMed
6345129Metoclopramide. An updated review of its pharmacological properties and clinical use.Drugs1983https://conductscience.org/library/papers/6345129PubMed
6162168Brain locations controlling the behavioral effects of chronic amphetamine intoxication.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6162168PubMed
6141584Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6141584PubMed
6119730Differential reversal of various dopamine antagonists by anticholinergics in Sidman avoidance: possible relationship to adrenergic blockade.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6119730PubMed
6112770Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6112770PubMed
4084483Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.Br J Ophthalmol1985https://conductscience.org/library/papers/4084483PubMed
3128811The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/3128811PubMed
3088638BRL 20596, a novel anilide with central dopamine antagonist activity.Psychopharmacology (Berl)1986https://conductscience.org/library/papers/3088638PubMed
2957718Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/2957718PubMed
2895483Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/2895483PubMed
2568655Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2568655PubMed
1678894Effects of cannabidiol in animal models predictive of antipsychotic activity.Psychopharmacology (Berl)1991https://conductscience.org/library/papers/1678894PubMed
44375Sulpiride in tardive dyskinesia.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/44375PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/692279

GET https://conductscience.org/api/papers/v1/692279/authors